Since c-Myc acts as a major metabolic regulator (Dejure and Eilers, 2017; Stine et al., 2015), we systematically investigated the c-Myc-dependent alterations in metabolite levels in response to bacterial infection and IFN-γ treatment. This evidence concerns the gene IFNG and bacterial infectious disease.